OTCM
VEXTF
Market cap40mUSD
Oct 08, Last price
0.18USD
1D
7.49%
1Q
6.77%
IPO
-87.01%
Name
Vext Science Inc
Chart & performance
P/E
—
P/S
0.83
EPS
—
Div yield, %
—
Shrs. gr., 5y
21.50%
Rev. gr., 5y
15.71%
Revenues
52m
+45.19%
Net income
-18m
L-18.39%
CFO
12m
+262.38%
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Vext Science, Inc. operates as a comprehensive enterprise within the United States' cannabis sector, encompassing agricultural technology, various services, and property management. The company is actively involved in cultivating, extracting, manufacturing, and distributing a range of THC and CBD products, including vape cartridges, concentrates, and edibles. Beyond production, it also manages retail dispensaries and handles the wholesale distribution of cannabis-derived THC and hemp-derived CBD products, marketed under its Vapen and Pure Touch Botanicals brands. Furthermore, its Vapen Kitchens line offers a diverse selection of infused edibles, such as Vapen clear products, THC chocolate bars, syrups, snacks, and various candies, including gummies. Established in 2015, the company was formerly known as Vapen MJ Ventures Corporation until it rebranded to Vext Science, Inc. in November 2019, with its headquarters situated in Phoenix, Arizona.
IPO date
May 13, 2019
Employees
Domiciled in
CA
Incorporated in
CA
Headquarters & legal address
1055 WEST GEORGIA STREET
1500 ROYAL CENTRE
PO BOX 11117
VANCOUVER, BC V6E 4N7
CA
1500 ROYAL CENTRE
PO BOX 11117
VANCOUVER, BC V6E 4N7
CA
Previous name
Vapen MJ Ventures Corporation
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | |
| Income | |||||||||
Revenues | |||||||||
Cost of revenue | |||||||||
Unusual Expense (Income) | |||||||||
NOPBT | |||||||||
NOPBT Margin | |||||||||
Operating Taxes | |||||||||
Tax Rate | |||||||||
NOPAT | |||||||||
Net income | |||||||||
Dividends | |||||||||
Dividend yield | |||||||||
Proceeds from repurchase of equity | |||||||||
BB yield | |||||||||
| Debt | |||||||||
Debt current | |||||||||
Long-term debt | |||||||||
Deferred revenue | |||||||||
Other long-term liabilities | |||||||||
Net debt | |||||||||
| Cash flow | |||||||||
Cash from operating activities | |||||||||
CAPEX | |||||||||
Cash from investing activities | |||||||||
Cash from financing activities | |||||||||
FCF | |||||||||
| Balance | |||||||||
Cash | |||||||||
Long term investments | |||||||||
Excess cash | |||||||||
Stockholders' equity | |||||||||
Invested Capital | |||||||||
ROIC | |||||||||
ROCE | |||||||||
| EV | |||||||||
Common stock shares outstanding | |||||||||
Price | |||||||||
Market cap | |||||||||
EV | |||||||||
EBITDA | |||||||||
EV/EBITDA | |||||||||
Interest | |||||||||
Interest/NOPBT | |||||||||